Spots Global Cancer Trial Database for Comparison Between the 19 and 22 Gauge Needles for Core Tissue Procurement During EUS-guided Procedures
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Comparison Between the 19 and 22 Gauge Needles for Core Tissue Procurement During EUS-guided Procedures
Official Title: Comparison Between the 19 and 22 Gauge Needles for Core Tissue Procurement During EUS-guided Procedures
Study ID: NCT02366858
Conditions
Study Description
Brief Summary: The investigators hypothesis is that a 22 gauge needle can yield core tissue, obviating the need to use the 19 gauge needle for core tissue procurement.
Detailed Description: Inclusion Criteria 1. Age under 19 years 2. Pregnant women will be excluded. This will be confirmed by self-report Exclusion Criteria 1. Age under 19 years 2. Pregnant women will be excluded. This will be confirmed by self-report
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Florida Hospital, Orlando, Florida, United States
Contact Details
Name: Shyam Varadarajulu, MD
Affiliation: AdventHealth
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
